Alpha 2.0
Login Register
» Authors » Henry Sunpath

Henry Sunpath

Explore the profile of Henry Sunpath including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 44
Citations 714
Followers 0
Related Specialties
Infectious Diseases
General Medicine
Science
Top 10 Co-Authors
Vincent C Marconi
Daniel R Kuritzkes
Selvan Pillay
Jaysingh Brijkumar
Rajesh T Gandhi
Brent A Johnson
Pravi Moodley
Richard A Murphy
Mahomed-Yunus S Moosa
Claudia E Ordonez
Published In
J Infect Dis
AIDS
PLoS One
J Acquir Immune Defic Syndr
AIDS Behav
Affiliations
Soon will be listed here.
Recent Articles
1.
Associations of inflammation-related proteome with demographic and clinical characteristics of people with HIV in South Africa
Chen J, Hui Q, Liu C, Brijkumar J, Edwards J, Ordonez C, et al.
Proteomics Clin Appl . 2023 Sep; 18(1):e2300015. PMID: 37672793
Purpose: Elevated levels of inflammation associated with human immunodeficiency virus (HIV) infection are one of the primary causes for the burden of age-related diseases among people with HIV (PWH). Circulating...
2.
Determinants of health-related quality of life in people with Human Immunodeficiency Virus, failing first-line treatment in Africa
Rautenberg T, Ng S, George G, Moosa M, McCluskey S, Gilbert R, et al.
Health Qual Life Outcomes . 2023 Aug; 21(1):94. PMID: 37605150
Background: Antiretroviral treatment improves health related quality of life (HRQoL) of people with human immunodeficiency virus (PWH). However, one third initiating first-line treatment experience virological failure and the determinants of...
3.
Food Insecurity Is Associated With Low Tenofovir Diphosphate in Dried Blood Spots in South African Persons With HIV
Hirsh M, Edwards J, Robichaux C, Brijkumar J, Moosa M, Ofotokun I, et al.
Open Forum Infect Dis . 2023 Jul; 10(7):ofad360. PMID: 37469618
Background: Food insecurity has been linked to suboptimal antiretroviral therapy (ART) adherence in persons with HIV (PWH). This association has not been evaluated using tenofovir diphosphate (TFV-DP) in dried blood...
4.
Point-of-care urine tenofovir testing to predict HIV drug resistance among individuals with virologic failure
McCluskey S, Govender K, Adamson J, Gandhi M, Spinelli M, Moosa M, et al.
AIDS . 2023 Mar; 37(7):1109-1113. PMID: 36928169
Objective: We sought to evaluate the utility of a point-of-care (POC) urine tenofovir (TFV) assay, developed to objectively assess adherence, to predict HIV drug resistance (HIVDR) in people failing first-line...
5.
Seemingly Unrelated Regression Analysis of the Cost and Health-Related Quality of Life Outcomes of the REVAMP Randomized Clinical Trial
Rautenberg T, Ng S, George G, Moosa M, McCluskey S, Gilbert R, et al.
Value Health Reg Issues . 2023 Mar; 35:42-47. PMID: 36863066
Objective: This study aimed to evaluate the 9-month cost and health-related quality of life (HRQOL) outcomes of resistance versus viral load testing strategies to manage virological failure in low-middle income...
6.
Crosstalk between Host Genome and Metabolome among People with HIV in South Africa
Liu C, Wang Z, Hui Q, Chiang Y, Chen J, Brijkumar J, et al.
Metabolites . 2022 Jul; 12(7). PMID: 35888748
Genome-wide association studies (GWAS) of circulating metabolites have revealed the role of genetic regulation on the human metabolome. Most previous investigations focused on European ancestry, and few studies have been...
7.
Comparing effectiveness of first-line antiretroviral therapy between peri-urban and rural clinics in KwaZulu-Natal, South Africa
Brijkumar J, Edwards J, Johnson B, Ordonez C, Sunpath H, Lee M, et al.
HIV Med . 2022 Jan; 23(7):727-737. PMID: 35023287
Objectives: Viral suppression (VS) is the hallmark of successful antiretroviral therapy (ART) programmes. We sought to compare clinic retention, virological outcomes, drug resistance and mortality between peri-urban and rural settings...
8.
Optimised electronic patient records to improve clinical monitoring of HIV-positive patients in rural South Africa (MONART trial): study protocol for a cluster-randomised trial
Iwuji C, Osler M, Mazibuko L, Hounsome N, Ngwenya N, Chimukuche R, et al.
BMC Infect Dis . 2021 Dec; 21(1):1266. PMID: 34930182
Background: There is poor viral load monitoring (VLM) and inadequate management of virological failure in HIV-positive individuals on antiretroviral therapy in rural KwaZulu-Natal, South Africa. This could be contributing to...
9.
Tenofovir diphosphate levels in dried blood spots are associated with virologic failure and resistance to first-line therapy in South Africa: a case-control cohort study
Castillo-Mancilla J, Edwards J, Brijkumar J, Moosa M, Zhao Y, Ofotokun I, et al.
J Int AIDS Soc . 2021 Dec; 24(12):e25849. PMID: 34910844
Introduction: Tenofovir diphosphate (TFV-DP) in dried blood spots (DBS), a measure of cumulative antiretroviral therapy (ART) adherence, is associated with viral suppression and predicts future viremia in persons with HIV...
10.
Who's slipping through the cracks? A comprehensive individual, clinical and health system characterization of people with virological failure on first-line HIV treatment in Uganda and South Africa
Reynolds Z, McCluskey S, Moosa M, Gilbert R, Pillay S, Aturinda I, et al.
HIV Med . 2021 Nov; 23(5):474-484. PMID: 34755438
Objectives: HIV virological failure remains a major threat to programme success in sub-Saharan Africa. While HIV drug resistance (HIVDR) and inadequate adherence are the main drivers of virological failure, the...